Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hazem Hamed Saleh"'
Autor:
Effrosyni Mendrinou, Mohamed Elsayed Mashaly, Amir Mohamed Al Okily, Mohamed Elsayed Mohamed, Ayman Fathi Refaie, Essam Mahmoud Elsawy, Hazem Hamed Saleh, Hussein Sheashaa, George P. Patrinos
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundTacrolimus is an approved first-line immunosuppressive agent for kidney transplantations. Part of interindividual and interethnic differences in the response of patients to tacrolimus is attributed to polymorphisms at CYP3A5 metabolic enzym
Externí odkaz:
https://doaj.org/article/5e8c082dea184679acfbbc0bf8a3e0d1
Autor:
Doaa Mohamed Riad, Wafaa Kamel Mowafy, Hazem Hamed Saleh, Essam Mahmoud El Sawy, Noha Tharwat Abou El-Khier
Publikováno v:
Egyptian Journal of Basic and Applied Sciences. 10:195-203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cfcbe7414d3d360bf4d8098fe1bed7e
https://doi.org/10.1080/2314808x.2023.2171580
https://doi.org/10.1080/2314808x.2023.2171580
Publikováno v:
Records of Pharmaceutical and Biomedical Sciences. 5:89-99
Background: The Extended spectrum β-lactamases (ESBLs) production is one of the most essential mechanism of drug resistance in Proteus mirabilis (P. mirabilis). Objective: Phenotypic and genotypic detection of extended spectrum β -lactamases produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7961d2f882a5ab4fab6b338d7f57f7b7
https://doi.org/10.21608/rpbs.2021.81598.1107
https://doi.org/10.21608/rpbs.2021.81598.1107
Treatment of hepatitis C infection among Egyptian hemodialysis patients: the dream becomes a reality
Autor:
Ayman F. Refaie, Khaled El-Dahshan, Mohamed A. Bakr, Yasser Elsayed Matter, Hanzada Mohamed El Maghrabi, Lionel Rostaing, Ahmed Yahia Elmowafy, Hazem Hamed Saleh, Gamal Shiha, M. Elbasiony
Publikováno v:
International urology and nephrology. 51(9)
New direct-acting antiviral drugs have become the corner-stone treatment for HCV infection: they show promising results with accepted side-effects and low dropout rates. One of the available regimens is paritaprevir/ombitasvir/ritonavir (PTV/OMV/RTV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0642cf915215150680d1e847136541c2
https://pubmed.ncbi.nlm.nih.gov/31363959
https://pubmed.ncbi.nlm.nih.gov/31363959
Autor:
Amir M Elokely, Ahmed Yahia Elmowafy, Essam Elsawy, Tamer M. Gouda, Hazem Hamed Saleh, Mahmoud H Zahran, Ahmed M. Abdel-Rahman, Ehab W. Wafa, Mohamed Kamal Ahmed Ibrahim
Publikováno v:
Journal of The Egyptian Society of Nephrology and Transplantation. 21:65
Background Variable prophylaxis regimens have been adapted to guard against cytomegalovirus (CMV) after renal transplantation. High-dose valganciclovir (VGCV) is the gold standard, but it is of very high cost. Herein, we compared another low-cost reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc9b1a9997e6aae66fead2e179472a31
https://doi.org/10.4103/jesnt.jesnt_41_20
https://doi.org/10.4103/jesnt.jesnt_41_20
Autor:
Ehab W. Wafa, Ahmed R. El-Nahas, Diaa-Eldin Taha, Essam A. El-Sawy, Mohamed M. Elsaadany, Tamer S. Barakat, Amira Awadalla, Khaled Z. Sheir, Hazem Hamed Saleh, Ahmed M. Elshal, Mohamed E. Abo El-Ghar, Amani M. Ismail
Publikováno v:
BJU international. 119(1)
To evaluate the protective effects of selenium with vitamins A, C and E (selenium ACE, i.e. antioxidants), verapamil (calcium channel blocker), and losartan (angiotensin receptor blocker) against extracorporeal shockwave lithotripsy (ESWL)-induced re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae14d349ac92b0d79e0543c4645697b7
https://pubmed.ncbi.nlm.nih.gov/27686059
https://pubmed.ncbi.nlm.nih.gov/27686059